Ardelyx Announces Abstract Exploring IBS-C Treatment Patterns Accepted for Poster Presentation at Digestive Disease Week 2026
Ardelyx, Inc. announced acceptance of an abstract on irritable bowel syndrome with constipation (IBS-C) treatment patterns for presentation at Digestive Disease Week 2026. The presentation explores patient characteristics linked to treatment changes and their impact on gastrointestinal healthcare resource use. Ardelyx will also sponsor a clinical d…